H Fujiwara1, S Fuji2, A Wake3, K Kato4, Y Takatsuka5, T Fukuda2, J Taguchi6, N Uchida7, T Miyamoto4, M Hidaka8, Y Miyazaki9, T Tomoyose10, M Onizuka11, M Takanashi12, T Ichinohe13, Y Atsuta14,15, A Utsunomiya5. 1. First Department of Internal Medicine, Ehime University Hospital, Ehime, Japan. 2. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. 3. Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan. 4. Department of Hematology and Oncology, Kyushu University Hospital, Fukuoka, Japan. 5. Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan. 6. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Hospital, Nagasaki, Japan. 7. Department of Hematology, Toranomon Hospital, Tokyo, Japan. 8. Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan. 9. Department of Hematology, Oita Prefecture Hospital, Oita, Japan. 10. Second Department of Internal Medicine, University Hospital, University of the Ryukyus, Okinawa, Japan. 11. Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan. 12. Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan. 13. Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan. 14. Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan. 15. Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Authors: Adrienne A Phillips; Paul A Fields; Olivier Hermine; Juan C Ramos; Brady E Beltran; Juliana Pereira; Farooq Wandroo; Tatyana Feldman; Graham P Taylor; Ahmed Sawas; Jeffrey Humphrey; Michael Kurman; Junji Moriya; Karen Dwyer; Mollie Leoni; Kevin Conlon; Lucy Cook; Jason Gonsky; Steven M Horwitz Journal: Haematologica Date: 2018-12-20 Impact factor: 9.941